Effect of complement 3 polymorphisms on long-term outcomes in renal transplant recipients
This article has no abstract so we have provided the first paragraph of the full text.
In humans, the immune response effector complement 3 exists as two main allotypes: complement 3 fast (C3F) and complement 3 slow (C3S). A C3F allele in donor kidneys might confer a long-term graft survival benefit to recipients who lack this variant. This is the exciting conclusion of a retrospective analysis published in the New England Journal of Medicine.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
